Development and optimization of levodopa and benzylhydrazine orally disintegrating tablets by direct compression and response surface methodology

Preparation of Cocoa Powder-Containing Orally Disintegrating Tablets of Rebamipide (Rebamipide Chocolet) and Evaluation of Their Clinical Palatability

(2019) Hidehito Takano et al.   CHEMICAL & PHARMACEUTICAL BULLETIN

Formulation and optimization of lyophilized nanosuspension tablets to improve the physicochemical properties and provide immediate release of silymarin

(2019) Ahmed H. Ibrahim et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Orally inhaled levodopa (CVT-301) for early morning OFF periods in Parkinson's disease

(2019) Robert A. Hauser et al.   PARKINSONISM & RELATED DISORDERS

A novel and discriminative method of in vitro disintegration time for preparation and optimization of taste-masked orally disintegrating tablets of carbinoxamine maleate

(2018) Yali Liu et al.   DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY

Development and evaluation of terbutaline sulfate orally disintegrating tablets by direct compression and freeze drying methods

(2018) Tugba Gulsun et al.   JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY

Optimization of biodiesel production from wet microalgal biomass by direct transesterification using the surface response methodology

(2018) M.D. Macías-Sánchez et al.   RENEWABLE ENERGY

Safinamide in the management of patients with Parkinson’s disease not stabilized on levodopa: a review of the current clinical evidence

(2018) Sagari Bette et al.   Therapeutics and Clinical Risk Management

Efficacy of carbidopa-levodopa extended-release capsules (IPX066) in the treatment of Parkinson Disease

(2018) Thomas Müller et al.   EXPERT OPINION ON PHARMACOTHERAPY

Optimization of ultrasonic assisted extraction of fatty acids from Aesculus hippocastanum fruit by response surface methodology

(2018) Shadan Amiri et al.   FOOD CHEMISTRY

Development and evaluation of orally disintegrating tablets comprising taste-masked mirtazapine granules

(2017) Simay Yıldız et al.   PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY

Optimized furosemide taste masked orally disintegrating tablets

(2017) Mohamed Abbas Ibrahim et al.   SAUDI PHARMACEUTICAL JOURNAL

Effects of levodopa/carbidopa intestinal gel versus oral levodopa/carbidopa on B vitamin levels and neuropathy

(2017) Sebastian Loens et al.   Brain and Behavior

Outlining critical quality attributes (CQAs) as guidance for the development of orodispersible films

(2016) Ana Filipa Borges et al.   PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY

Preclinical and clinical assessment of inhaled levodopa for OFF episodes in Parkinsons disease

(2016) M. M. Lipp et al.   Science Translational Medicine

The prediction of the palatability of orally disintegrating tablets by an electronic gustatory system

(2015) Hideshi Nakamura et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Formulation and evaluation of a montelukast sodium orally disintegrating tablet with a similar dissolution profile as the marketed product

(2015) Yong Chen et al.   PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY

Development and Evaluation of Orally Disintegrating Tablets of Montelukast Sodium by Direct Compression Method

(2015) MT Usmani et al.   TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH

Development and evaluation of orally disintegrating tablets of cilostazol-β-cyclodextrin inclusion complexes

(2014) Chirag Desai et al.   DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY

Freeze drying of orally disintegrating tablets containing taste masked naproxen sodium granules in blisters

(2014) Ulrike Stange et al.   PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY

Phenylalanine-free taste-masked orodispersible tablets of fexofenadine hydrochloride: development,in vitroevaluation andin vivoestimation of the drug pharmacokinetics in healthy human volunteers

(2014) Soad Ali Yehia et al.   PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY

Clinical Disintegration Time of Orally Disintegrating Tablets Clinically Available in Japan in Healthy Volunteers

(2013) Tomohiro Yoshita et al.   BIOLOGICAL & PHARMACEUTICAL BULLETIN

Development and evaluation of ofloxacin orally disintegrating tablets

(2013) Badrinath Pralhadrao Mohite et al.   Brazilian Journal of Pharmaceutical Sciences

Pharmacokinetics of Levodopa/Carbidopa Microtablets Versus Levodopa/Benserazide and Levodopa/Carbidopa in Healthy Volunteers

(2012) Dag Nyholm et al.   CLINICAL NEUROPHARMACOLOGY

Development and evaluation of orally disintegrating tablets (ODTs) containing Ibuprofen granules prepared by hot melt extrusion

(2011) Andreas Gryczke et al.   COLLOIDS AND SURFACES B-BIOINTERFACES

Orally disintegrating mini-tablets (ODMTs) – A novel solid oral dosage form for paediatric use

(2011) I. Stoltenberg et al.   EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS

Orally Disintegrating Tablets: A Review

(2011) J J Hirani et al.   TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH

Design and evaluation of taste masked dextromethorphan hydrobromide oral disintegrating tablets

(2010) Madhusudhan Malladi et al.   ACTA PHARMACEUTICA

Development of a New Disintegration Method for Orally Disintegrating Tablets

(2010) Ryo Kakutani et al.   CHEMICAL & PHARMACEUTICAL BULLETIN

Comparison of orally dissolving carbidopa/levodopa (Parcopa) to conventional oral carbidopa/levodopa: A single-dose, double-blind, double-dummy, placebo-controlled, crossover trial

(2010) William G. Ondo et al.   MOVEMENT DISORDERS